Carmer Scott 4
4 · NexImmune, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Carmer Scott
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-02-11+306,842→ 770,923 totalExercise: $17.00Exp: 2025-02-11→ Common Stock (306,842 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the first anniversary of the grant date (the "Initial Vesting Date") (2/11/2021) and 1/48 of the shares subject to the option shall vest on each month anniversary of the Initial Vesting Date such that after four (4) years, all shares subject to the option shall be vested, subject to the participant's continuous service on each such vesting date.